Allan Christian Shaw

Title: Innovations in Protein Purification by Inventor Allan Christian Shaw

Introduction

Allan Christian Shaw is a distinguished inventor located in Copenhagen, DK, known for his significant contributions to the field of biotechnology. With five patents to his name, he has made remarkable strides in developing methods for protein purification and modification.

Latest Patents

Among his latest inventions are two notable patents focused on enhancing the purification and modification of proteins. The first patent revolves around "Basic protein purification tags from thermophilic bacteria," which introduces a method for purifying recombinant proteins using highly basic proteins from thermophilic bacteria as purification tags. These tags are particularly useful in cation-exchange chromatography purification steps and typically exhibit a pI above 9, comprising between 15 to 250 amino acid residues.

The second patent pertains to "Processing enzymes fused to basic protein tags," presenting an innovative approach where processing enzymes incorporate an N-terminally attached tag derived from highly basic proteins from thermophilic bacteria. This invention allows for the efficient production of these enzymes in high yields and enables effective separation from the modified proteins post-use, significantly enhancing their utility in protein modification processes.

Career Highlights

Allan is currently associated with Novo Nordisk Healthcare AG, where he leverages his expertise in protein chemistry and biotechnology to drive innovation. His work is critical in advancing therapeutic applications that rely on recombinant proteins.

Collaborations

Throughout his career, Allan has collaborated with notable colleagues, including Susanne Bang and Jing Su. These partnerships have fostered a rich environment for innovation, allowing them to combine their expertise and contribute to developments that push the boundaries of biotechnology further.

Conclusion

Allan Christian Shaw’s work exemplifies the intersection of science and innovation, particularly in the field of protein purification and modification. His patents are notable contributions that equip biotechnologists with powerful tools for improving protein production and application in therapeutic contexts. As he continues his research at Novo Nordisk Healthcare AG, the impact of his inventions is surely set to grow even further.